Gujarat Kidney & Super Speciality Ltd (GKSL) is currently trading at 160.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Gujarat Kidney and Super Speciality Limited operates a regional chain of mid-sized multispeciality hospitals across central Gujarat, combining secondary and tertiary care with diagnostics, pharmacies, renal sciences, urology, cardiology, oncology and other specialties. Its model integrates leased hospitals with controlling stakes in established facilities, seeking affordable, patient-centric healthcare through specialist-led operations. The company delivered exceptional reported scale-up in Q2 FY27, with operating revenue rising 195% year-on-year to ₹3,809 lakhs and PAT increasing 129% to ₹660 lakhs. However, the comparison is influenced by acquisitions and consolidation, making integration quality, organic growth and sustainable margins more important than headline growth alone. Inorganic expansion has become the primary strategic engine, with ₹1,669 lakhs invested in acquisitions during H1 FY27 and goodwill reaching ₹10,742 lakhs. The network now includes hospitals across Vadodara, Godhra, Bharuch, Anand, Borsad, Ahmedabad, Ankleshwar, Zadeshwar and Dubai, although several facilities remain at moderate occupancy levels. The company is extending its specialist platform beyond Gujarat through a 51% stake in Blue Tree Clinics, a Dubai polyclinic reporting ₹20–25 crore equivalent revenue for January–June 2026. Management intends to use the Dubai presence for international patient sourcing and potential medical-tourism referrals into its Gujarat specialist network.

Over the past 52 weeks, Gujarat Kidney & Super Speciality Ltd has traded between a low of ₹98.25 and a high of ₹210.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Gujarat Kidney & Super Speciality Ltd has a market capitalization of approximately 1,259.52. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Gujarat Kidney & Super Speciality Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 61.56 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 1,259.52 Cr, Gujarat Kidney & Super Speciality Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Gujarat Kidney & Super Speciality Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Gujarat Kidney & Super Speciality Ltd is 61.56. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.